Clínica Baviera, S.A. Reports Unaudited Consolidated Earnings Results for the Second Quarter and First Half of 2017
July 30, 2017
Share
Clínica Baviera, S.A. reported unaudited consolidated earnings results for the second quarter and first half of 2017. For the quarter, the company reported revenues of €25,333,000 and EBITDA of €4,543,000.
For the period, the company has posted revenues of €50,150,000 against €47,521,000 a year ago. EBITDA was €9,423,000 against €9,680,000 a year ago. EBIT was €6,818,000 against €7,289,000 a year ago. Profit before taxes was €6,710,000 against €7,136,000 a year ago. Net profit was €5,009,000 against €5,260,000 a year ago. Capital expenditure was €2,775,000 a year ago. Net debt was €4,875,000. Property, plant and equipment were €18,791,000 against €18,175,000 a year ago. Cash flow from operations was €7,368,000.
Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The Company operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.
CLÍNICA BAVIERA, S.A. 
